Cure My Disease

Don't miss your cure!

 Log in / Sign up

Catheter study finds symptom relief for fluid buildup

NCT ID NCT06436807

Symptom relief Sponsor: ewimed GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a catheter already used in clinics to drain extra fluid from the chest or belly. Researchers wanted to see if it works well, is safe, and helps relieve symptoms like pain. A total of 169 patients took part, and doctors tracked how the device performed during regular care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

169 people

The number who actually took part.

Started

Jun 2024

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with recurrent, refractory, malignant and non-malignant effusions in serous body cavities according to the IFU.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients ≥ 18 years old * Patients being able to give informed consent Exclusion Criteria: Patients with any contraindication according to the IFU: * presence of septa in the body cavity * coagulopathy * infection in the body cavity * lymphatic effusion * shift of the mediastinum (by more than 2 cm to the ipsilateral side of the pleural effusion) * known allergies to any of the materials used in the drainage product

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ascites are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ascites Pleural Effusion Pleural Effusion, Malignant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ascites Ascites, malignant Pleural effusion Pleural effusion, malignant

Contacts and locations

Locations

  • Asklepios Lungenklinik Gauting

    Gauting, 82131, Germany

  • Charité Universitätsmedizin Berlin

    Berlin, 10117, Germany

  • Clemenshospital

    Münster, 48153, Germany

  • Klinikum Chemnitz gGmbH

    Chemnitz, 09113, Germany

  • Klinikum Chemnitz gGmbH MVZ Flemmingstraße

    Chemnitz, 09116, Germany

  • Krankenhaus Barmherzige Brüder

    Regensburg, 93049, Germany

  • Lungenklinik Hemer

    Hemer, 58675, Germany

  • Medizinische Hochschule Hannover

    Hanover, 30625, Germany

  • Universitätsklinikum Augsburg

    Augsburg, 86156, Germany

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, 79106, Germany

  • Universitätsklinikum Heidelberg

    Heidelberg, 69126, Germany

  • Universitätsklinikum Regensburg

    Regensburg, 93053, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.